Here are three things to know:
1. ApoGraft-treated human fat-derived stem cells significantly improved rotator cuff repair in animals with a shorter incubation compared to traditional adipose-derived stem cells.
2. Prior to this study, ApoGraft was mainly used in hematopoietic applications. Results from a phase 1/2 study of the technology indicated 100 percent engraftment with no reported procedure-related adverse events in 12 patients with hematological malignancies.
3. Israel-based Cellect Biotechnology develops stem cell selection technology for the regenerative medicine market.
More articles on biologics:
Kuros Biosciences seeks spinal fusion product expansion: 4 things to know
3 things to know about Reinvent Biologics
‘A new dawn’ for orthopedics: Dr. Jason Arora on the promise of biologics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
